Product
UCB
1 clinical trial
1 indication
Indication
lung cancerClinical trial
Radio-Immuno-Modulation for Advanced Lung Cancer: a Pilot Study Evaluating Tolerance and Immune ResponsesStatus: , Estimated PCD: 2024-10-01
1 clinical trial
1 indication